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Summary 
Human Vy2VS2 + T cells recognize mycobacterial non- 
peptide antigens, such as isopentenyl pyrophosphate, 
and their synthetic analogs, such as monoethyl phos- 
phate, through a TCR-dependent process. Here, we 
examine the presentation of these antigens. Vy2VS2+ 
T cells recognized secreted prenyl pyrophosphate an- 
tigens in the absence of other accessory cells but, un- 
der such conditions, required T cell-T cell contact. 
Recognition required neither the expression of classi- 
cal MHCclassI, MHCclassII,orCDla,CDlb,andCDlc 
molecules, nor MHC class I or class II peptide loading 
pathways. Fixed accessory cells also presented the 
prenyl pyrophosphate antigens to yS T cells. Thus, in 
contrast with the presentation of conventional peptide 
antigens, protein antigens, and superantigens to af3 T 
cells, prenyl pyrophosphate antigens are presented to 
$3 T cells through a novel extracellular pathway that 
does not require antigen uptake, antigen processing, 
or MHC class I or class II expression. This pathway 
allows for the rapid recognition of bacteria by yS T cells 
and suggests that yS T cells play a role in the early 
response to bacterial infection. 
Introduction 
Two distinct CDS-associated antigen receptors, T cell re- 
ceptor a6 (TCRa8) and TCRyS, are expressed on separate 
populations of T lymphocytes. up T cells predominantly 
recognize foreign and self-peptides presented by MHC 
class I and class II molecules (Germain and Margulies, 
1993; Yewdell and Bennink, 1992). This recognition is me- 
diated by antigen receptors encoded by a variety of Vu 
and Vg gene segments with diverse V(D)J junctional se- 
quences. In contrast, the antigen receptors of y6 T cells 
use only a few Vy and VS gene segments with the 6 chain 
exhibiting marked diversity in the length and amino acid 
sequence of its V(D)(D)(D)J joining region (Porcelli et al., 
1991; Rock et al., 1994). Most y6 T cells do not express 
CD4 or CD8 (Groh et al., 1989) but are capable of effector 
functions such as cytolysis and secretion of multiple cyto- 
kines, including interleukin-2 (IL-2), IL-4, IL-5 interferon-y 
(IFNy), tumor necrosis factor-a, and granulocytelmacro- 
phage colony-stimulating factor (Morita et al., 1991). 
Antigen recognition by yS T cells is not well understood 
(Haas et al., 1993; Porcelli et al., 1991). Few y6 T cells 
have been reported to respond to peptide antigens in a 
major histocompatibilitycomplex(MHC)-restricted fashion 
(Holoshitz et al., 1992; Kozbor et al., 1989) or to be allore- 
active (Kabelitz et al., 1990a). However, recent evidence 
suggests that large numbers of y6 T cells do respond to 
foreign microbial pathogens. In mice, yS T cells expand 
in response to mycobacteria, listeria, and salmonella in- 
fections (Augustin et al., 1989; Emoto et al., 1992; Fu et 
al., 1993; Hiromatsu et al., 1992; lnoue et al., 1991; Janis 
et al., 1989). Mice lacking yS T cells develop liver ab- 
scesses in response to listeria infections, and mice that 
have yS T cells but lack up T cells can survive listeria 
and malaria infections that kill pan T cell-deficient mice 
(Mombaerts et al., 1993; Tsuji et al., 1994). In humans, 
y6 T cells dramatically expand in vivo (up to 45% of all 
T cells in the peripheral blood) following infections with 
bacteriasuch as Mycobacterium tuberculosis, Salmonella 
typhi, Brucella melitensis, and Francisella tularensis(Balbi 
etal., 1993;Barnesetal., 1992;Bertottoetal., 1993;Hara 
et al., 1992; Sumida et al., 1992) and following infections 
with parasites such as Plasmodium vivax and Plasmodium 
falciparum (Ho et al., 1990; Perera et al., 1994). Similarly, 
y6 T cells expand upon in vitro culture of lymphocytes with 
soluble extracts of mycobacteria (Holoshitz et al., 1989; 
Kabelitz et al., 1990b; Modlin et al., 1989) salmonella 
(Haraet al., 1992) andother pathogens(Behrand Dubois, 
1992; Bender and Kabelitz, 1992). The human y6 T cells 
expanded by these pathogens express Vy2 and V62 TCR 
gene segments. Responses to pathogens by these cells 
are relatively independent of their junctional region se- 
quences, a characteristic in common with the VP-related 
activation of a8 T cells by superantigens. 
The mycobacterial antigens that expand Vy2VS2+ T 
cells are small (<500 Da), protease resistant, and contain 
critical phosphate moieties (Constant et al., 1994; Pfeffer 
et al., 1990; Schoel et al., 1994; Tanaka et al., 1994). Re- 
cently, we have determined the structure of these natural 
antigens as isopentenyl pyrophosphate (IPPP) and a re- 
lated prenyl pyrophosphate, important intermediates for 
many critical biosynthetic pathways based on isoprenoid 
subunits in both prokaryotes and eukaryotes (Tanaka et 
al., 1995). lsoprenoid subunits are required for the synthe- 
sis of dolicol phosphates (membrane components im- 
portant for carbohydrate attachments), carotenoids (vita- 
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min A compounds), ubiquinones (respiratory proteins in 
bacteria), and cholesterol and sterol compounds. Nucleo- 
tide conjugates of IPPP and related compounds also stim- 
ulate Vy2V62’T cells (Constant et al., 1994; Tanaka et al., 
1995). A synthetic analog of IPPP, monoethyl phosphate 
(MEP), precisely mimics the ability of IPPP to stimulate 
human $3 T cells (Tanaka et al., 1994). Thus, this group 
of nonpeptide antigens recognized by y6 T cells are funda- 
mentally distinct from conventional protein antigens or 
protein superantigens recognized by a6 T cells. 
The unusual chemical structure of these nonpeptide an- 
tigens suggests that they may be presented to y6 T cells 
in a distinct manner. Conventional protein antigens are 
presented to a6 T cells through two major presentation 
pathways (Germain and Margulies, 1993). In the MHC 
class I pathway, peptides generated from endogenous cy- 
toplasmic proteins are transported into the endoplasmic 
reticulum, and associate with MHC class I heavy chains 
and pp-microglobulin (ILm). In the MHC class II pathway, 
peptides generated from extracellular proteins associate 
with the MHC class II molecules in the acidic endosomal 
environment. In contrast, superantigens do not require 
processing, because they are proteins that bind directly 
to MHC class II molecules on the cell surface and to the 
TCR 6 or TCR y chain of the TCR (Herman et al., 1991). 
In this study, we show that the recognition of secreted 
prenyl pyrophosphate antigens by human yS T cells could 
be accessory cell independent and did not require pro- 
cessing. Unlike presentation pathways for af3 T cells, pre- 
nyl pyrophosphate antigen presentation did not require 
the expression of known antigen-presenting molecules, 
including classical MHC class I, MHC class II, CDla, 
CD1 b, CD1 c, or other &m-dependent molecules. Antigen 
internalization also was not required as fixed accessory 
cells were able to present the prenyl pyrophosphate anti- 
gens. Moreover, these antigens could not be “pulsed”onto 
accessory cells and needed to be present continuously 
during T cell stimulation. Thus, we propose that prenyl 
pyrophosphate antigens are presented through a novel 
extracellular pathway of presentation that does not require 
antigen internalization or processing. This pathway allows 
for the rapid recognition of bacteria by $3 T cells and sug- 
gests that yS T cells play a role in the early response to 
bacterial infection. 
Results 
y6 T Cells Respond to Secreted 
Mycobacterial Antigens 
To determine whether the prenyl pyrophosphate antigens 
of mycobacteria were secreted or were sequestered in the 
cytoplasm of the bacterium, M. fortuitum was cultured in 
vitro for varying periods of time, harvested, and sonicated. 
The amounts of biological activity in the mycobacterial 
extracts and the culture broth were quantitated by stimula- 
tion of the Vy2V62’clone, DGSF66. The level of biological 
activity in the culture broth increased with time until consti- 
tuting 75% of the total biological activity (Figure 1A). Since 
the logarithmic phase of mycobacterial growth was tested, 
it was unlikely that significant bacterial death was oc- 
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Figure 1, Mycobacterial Secretion of Prenyl Pyrophosphate Antigens 
for y& T Cells 
(A) Secretion of prenyl pyrophosphate antigens by mycobacteria. M. 
fortuitum was cultured for the indicated period in Middlebrook’s media. 
The optical density of the bacteria was measured at 600 nm at each 
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curring. Other mycobacterial strains, including M. tubercu- 
iosis and M. smegmatis, as well as Gram-negative bacte- 
ria, such as Escherichia coli and Xanthamonas maltiphilia, 
also secreted antigenic activity (data not shown). This se- 
cretion of natural prenyl pyrophosphate antigens into the 
timepoint from separate cultures set up in parallel. The bacteria from 
50 ml of media then were harvested by centrifugation and probe soni- 
cated. The total bioactivity was determined for the spent media and 
the bacterial lysates by bioassay. 
(6) Recognition of mycobacteria by yS T cells does not require direct 
contact between the mycobacteria and the T cells or APCs. Live M. 
smegmatis mycobacteria were serially diluted and added to the inner 
wells of transwells, where they were separated from the outer wells 
by a 0.4 pm membrane. The yS T cell clone, CP.1.15 (closed square), 
the mycobacteria-specific CD4’ ap T cell line, DG.1 (open circle), or 
the tetanus toxin-specific CD4’ a!3 T cell clone, SP-F3 (open triangle) 
were added to the ,outer wells (5 x 10’ cells/well) with mitomycin 
C-treated DG.EBV cells (5 x 10’ cells/well). After culture for 24 hr in 
the presence of 0.03 nM rlL-2, the cells in the outer wells were resus- 
pended and 0.2 ml of the cell suspension added to three wells of a 
96-well plate. Each well was pulsed with [3H]thymidine, and harvested 
24 hr later. Positive controls included stimulation with phytohemagglu- 
tinin for CP.l.15 (5,426 mean cpm) and SP-F3 (27,315 mean cpm) 
and with M. smegmatis extract for DG.l (5,223 mean cpm). 
C 
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Figure 2. Response of Vy2VS2’ T Cell Clones to Prenyl Pyrophos- 
phate Antigens in the Absence of Other Accessory Cells 
(A) Vy2VW T cell clones were cultured in the absence (open bars) 
or presence of M. tuberculosis extract (closed bars) with (right) or 
without (left) PBMC as a source of APC and accessory cells. Note 
that although CD4-CD6- and CD6’ y6 clones proliferated without the 
requirement for PBMC, the CD4+ ~6 clones, HF.2, JN.23, and JN.24, 
required PBMC for proliferation. 
(B) Purified populations of the y6 T cell clone, DG.SF66, proliferate 
to prenyl pyrophosphate antigens in the absence of other cell types. 
Resting T cell cultures were stained with MAbs against the CD1 4 mac- 
rophage surface marker and the complement receptor 1 (CD35) B 
cell surface marker and then residual macrophages and B cells were 
negatively deleted with magnetic beads. A portion of the resulting 
purified T cell population was stained with FITC-control or FITC-anti-6 
chain MAbs and analyzed by flow cytometry. The purified DGSF66 
cells were used in a proliferation assay in the absence (left) or presence 
(right) of PBMC with MEP (closed triangle), MMP (closed circle), or 
mycobacterial extract (closed square). 
(C)TheCP.l.l5ySTcell cloneproliferatesin theabsenceof accessory 
cells to natural antigens from mycobacterial supernatant or to synthetic 
isopentenyl pyrophosphate. T cells were cultured in the absence (left) 
or presence (right) of PBMC with mycobacterial supernatant (closed 
diamond), isopentenyl pyrophosphate (31.6 uM) (closed circle), di- 
methylallyl pyrophosphate (31.6 NM) (closed square), or MEP (closed 
triangle). 
extracellular environment suggested that $5 T cells may 
encounter free antigen in vivo. 
To extend these observations, the recognition of se- 
creted prenyl pyrophosphate antigens of mycobacteria 
was assessed in a transwell system. For these experi- 
ments, live mycobacteria were placed in an inner well sep- 
arated by a 0.4 pm membrane from an outer well con- 
taining Epstein-Barr virus (EBV)-transformed B cells and 
either up or y6 T cells. The membrane prevented the pas- 
sage of whole bacteria but allowed soluble molecules to 
pass through. As expected, a mycobacteria-specific up 
T cell line (that reacts with sonicated M. smegmatis ex- 
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tracts presented by the B cell line), and a tetanus toxin- 
specific up T cell clone did not proliferate when physically 
separated from the mycobacteria (Figure 16). In contrast, 
the VyZV62’T cells proliferated strongly despite the physi- 
cal separation of the mycobacteria and the yS T cells and 
the B cell line (Figure 16). Thus, neither phagocytosis of 
whole mycobacteria or its fragments by antigen-present- 
ing cells (APCs) nor direct contact with mycobacteria by 
either APC or yS T cells was required for antigen recogni- 
tion. Instead, Vy2V62+ T cells could respond to secreted 
prenyl pyrophosphate antigens from live mycobacteria. 
Vy2V62+ T Cell Clones Can Respond to Prenyl 
Pyrophosphate Antigens in the Absence 
of Accessory or APCs 
We next sought to determine whether accessory or APCS 
were required for the recognition of the mycobacterial anti- 
gens. A panel of Vy2VS2+ T cell clones derived from adult 
blood or synovial fluid was tested for responsiveness to 
antigens present in M. tuberculosis extracts in the pres- 
ence or absence of other cells. As expected, all Vy2V62+ 
T cell clones responded to the M. tuberculosis extract, 
including those that were CD4-CD8-, CD8+, and CD4+ 
(Figure 2A). While all of the clones responded in the pres- 
ence of peripheral blood mononuclear cells (PBMCs) as 
APCs and low levels of human IL-2 (Figure 2A, right), sur- 
prisingly, most clones also responded in the absence of 
PBMC, although at lower levels(Figure 2A, left). To ensure 
that no macrophages or B cells remained in the T cell 
populations, the DG.SF68 clone was treated to remove 
potential accessory cells by negative magnetic bead dele- 
tion with monoclonal antibody (MAb) to CD14 (a macro- 
phage marker) and to the complement receptor, CR2 (a 
B cell marker). FACS analysis confirmed that non-T cells 
comprised less than 0.3% of the purified DG.SF68 popula- 
tion. These purified T cells responded strongly to the M. 
tuberculosis extract as well as to the synthetic monoalkyl 
phosphates, MMP and MEP (Figure 28, left). Similarly, a 
second $5 T cell clone, CP.1.15, proliferated when cul- 
tured in the absence of other cells with either mycobacte- 
rial supernatant, synthetic isopentenyl pyrophosphate, or 
MEP (Figure 2C, left). The low level of proliferation of some 
CD4-CD8- $5 T cell clones when exposed to prenyl pyro- 
phosphate antigens in the absence of other cells was aug- 
mented significantly by the addition of rlL-2 (data not 
shown) or by the addition of accessory cells (Figures 2A, 
28, and 2C). Thus, accessory cells may play a role in 
prenyl pyrophosphate recognition by providing IL-2, by in- 
creasing the synthesis of IL-2 by yS T cells, or by providing 
other undefined signals. However, y8 T cell recognition 
of the prenyl pyrophosphate antigens clearly occurred in 
the absence of these signals. 
To confirm further that the recognition of prenyl pyro- 
phosphate antigens could occur in the absence of other 
cells, we tested the ability of the Vy2V62 TCR transfectant, 
DBS43, to recognize prenyl pyrophosphate antigens (Bu- 
kowski et al., 1995). This tumor cell line was cultured con- 
tinuously without the addition of feeder cells and therefore 
represented a pure T cell population. The DBS43 transfec- 
tant specifically released IL-2 when exposed either to syn- 
DG.SF13 DBS43 
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Figure 3. IL-2 Release to Monoethyl Phosphate by the Vy2V62 TCR 
Transfectant, DBS43, in the Absence of Accessory Cells 
The DES43 transfectant or the TCR-parent DG.SFi 3 T cell clone was 
incubated with MEP for 24 hr in the absence (open circle) or presence 
of varying numbers of DG.EBV cells (5 x lo4 [closed circle], 1 x 105 
[closed triangle], and 2 x lo5 [closed square1 per well). The superna- 
tants then were harvested and IL-2 levels were assessed by prolifera- 
tion of the IL-2-dependent CTLLPO cell line. In the absence of MEP, 
the DBS43 transfectant did not release detectable 11-2. Note that the 
DBS43 transfectant did not require DG.EBV cells for maximal IL-2 
release, whereas the TCR parent DG.SF13 clone required DG. EBV 
cells for maximal IL-2 release. 
thetic MEP (Figure 3, right) or to mycobacterial extracts 
(data not shown). The addition of the autologous EBV- 
transformed B cell line as a possible APC resulted in a 
minor enhancement (approximately P-fold) in the DBS43 
IL-2 response. The parent T cell clone, DG.SF13, from 
which the DBS43 TCR cDNAs were cloned, also re- 
sponded either to MEP (Figure 3, left) or to mycobacteria 
(data not shown), although the addition of the B cells aug- 
mented the amount of IL-2 released in response to MEP 
by 50-fold. Thus, Vy2V82’ T cells could respond both to 
natural mycobacterial antigens and to synthetic monoalkyl 
phosphates in the absence of other cells. Although acces- 
sory cells or APCs were not required by most V-r2V62+ T 
cells, the presence of accessory cells or APCs augmented 
the magnitude of the responses. Interestingly, the group 
of y8 clones that did require accessory cells for prenyl 
pyrophosphate recognition (clones HF.2, JN.23, and 
JN.24) are from the distinct functional subset of CD4+ y6 
T cells (Morita et al., 1991; Spits et al., 1991) and thus, 
this subset may have presentation requirements distinct 
from most yS T cells. 
T Cell-T Cell Contact Is Required for the Recognition 
of Prenyl Pyrophosphate Antigens 
in the Absence of APCs 
As most Vy2VS2+ T cells could respond to prenyl pyro- 
phosphate antigens in the absence of other cell types, it 
was possible that yS T cells recognized these antigens 
alone in solution. Alternatively, presentation could have 
occurred through the ability of yS T cells to associate with 
the prenyl pyrophosphate antigens and to present them 
to neighboring T cells. Such T cell presentation of antigen 
has been demonstrated for MHC class I- and II-restricted 
af3 T cell clones in the presence of preprocessed peptides 
(LaSalle et al., 1993; Pichler and Wyss-Coray, 1994; Su 
et al., 1993; Suhrbier et al., 1993). 
Presentation of Prenyl Pyrophosphate Antigens to y6 T Cells 
499 
To determine the mechanism of recognition employed 
by$Tcells, calcium flux byaySTcell clone was assessed 
following exposure to prenyl pyrophosphate antigens. For 
thesestudies, theDG.SF66ySTcellclone wasloadedwith 
the calcium indicator, indo-l , and the intracellular calcium 
levels of the T cell clone (expressed as the mean ratio of 
indo-l fluorescence at 410/460 nm) were determined by 
flow cytometry. Following the addition of MEP or mycobac- 
terial extract (Figure 4A, upper left, first arrow) to a single 
cell suspension of DG.SF66 cells, intracellular calcium lev- 
els were determined for 6 min. No calcium flux was de- 
tected for such a suspension of single cells (Figure 4A, 
upper left). However, when an identical aliquotof DG.SF66 
cells in suspension with MEP was centrifuged for 0.5 min 
to effect cell-cell contact (Figure 4A, upper right, second 
arrow), resuspended, and analyzed by flow cytometry, a 
clear peak of calcium flux (3- to 5-fold increase over base- 
line levels) occurred, indicating TCR signaling (Figure 4A, 
upper right). No such calcium flux was noted in control 
a6 T cells (Figure 4A, bottom). 
To examine directly whether solitary T cells were capa- 
ble of responding to prenyl pyrophosphate antigens, ~5 
T cells were exposed to the synthetic analog MEP, and 
cellular calcium flux was assessed by microscope-based 
laser cytometry. Indo-l-loaded T cells were observed indi- 
vidually under a microscope and intracellular calcium lev- 
els were determined by the ratio of indo-l fluorescence 
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at 400 nm to that at 480 nm. As seen in representative 
pseudocolor images (Figure 46, top), solitary y6 T cells 
exposed to MEP exhibited no change in intracellular cal- 
cium levels (as represented by the blue color), although 
exposure to a calcium ionophore caused large increases 
in intracellular calcium levels (as represented by the 
green-red color). In contrast, T cells exposed to MEP and 
placed in contact with other T cells by centrifugation exhib- 
ited increases in intracellular calcium levels (Figure 48, 
bottom middle, see clusters of green-yellow cells). No 
such increases in calcium levels were seen after centrifu- 
gation in the absence of MEP (Figure 48, bottom left). 
Thus, unlike compounds such as ionomycin, neurotrans- 
mitters, and hormones, which activate individual cells 
without a cell-cell contact requirement, the activation of 
yS T cells by prenyl pyrophosphate antigens required cell- 
cell contact. 
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Figure 4. TCell-TCell Contact Is Required for 
Calcium Flux to Prenyl Pyrophosphate Anti- 
gens in the Absence of Accessory Cells 
(A) Determination of calcium flux by flow cytom- 
etry. The Vy2V62’ T ceil clone, DG.SF66 (top), 
or the MEP-specific a6 clone, 2Hy.266.2 (bot- 
tom), were loaded with indo-l and assessed for 
calcium flux by flow cytometry. Media (closed 
square), MEP (closed circle), or M. tuberculosis 
extract (closed triangle) was added at the first 
arrow and, at the second arrow, the cells were 
centrifuged for 1 min (right) and reapplied to 
the cytometer after 2-3 min. or were not centri- 
fuged (left). The mean indo-l ratio is plotted. 
Note that calcium flux by the y6 T cell was seen 
with both MEP and the mycobacterial extract 
onlyaftercentrifugation resulted inTcell-Tcell 
contact. No such cell-cell contact requirement 
was noted for calcium flux induction by mito- 
genie TCR signaling with a polyvalent IgM anti- 
CD3 MAb or with the calcium ionophore. iono- 
mycin (data not shown). 
(B) Determination of relative intracellular cal- 
cium ion concentrations in individual T cells by 
interactive laser cytometry. The y6 T cell clone, 
CP.1.15, was loaded with indo-l and analyzed 
for [Ca%], response at 4-6 min to media (left), 
MEP (l/l000 dilution, middle), or ionomycin (2 
@g/ml, right) without (top) or with (bottom) cen- 
trifugation to effect cell-cell contact, The colori- 
metric scale represents relative units of [Ca*+], 
based on the ratio of indo-l fluorescence inten- 
sities at 400 nm and 460 nm. Representative 
micrographs are shown. The percentage of re- 
sponsive T cells (indo-l ratio > 2.0) under each 
condition was 0% (0 of 14 cells) for not spun- 
media; 6% (1 of 12 cells) for not spun-MEP; 
96% (25 of 26 cells) for not spun-ionomycin; 
7% (5 of 77 cells) for spun-media; 63% (47 of 
73cells)forspunMEP; and92%(24of 26cells) 
for spun-ionomycin. Note the increased cal- 
cium ratio in the clusters of T cells upon centrif- 
ugation in the presence of MEP (middle panel, 
bottom). 
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Recognition of Prenyl Pyrophosphate Antigens 
Does Not Require WHC Class II, Classical MHC 
Class I, Pzm, CDl, TAPlRAPP, 
or DMA/DMB Expression 
Since cell-cell contact was necessary for the recognition 
of the prenyl pyrophosphate antigens by yS T cells, we 
examined the requirement for the expression of known 
antigen-presenting molecules for this recognition using 
several approaches. First, MAbs against MHC class I, 
MHC class II, PPm, or CD1 molecules were used to attempt 
to block the recognition of nonpeptide antigens in cytolytic 
or proliferative assays. Second, the Vy2V62 TCR transfec- 
tant, DBS43, was examined for MHC class II expression. 
Lastly, mutant cell lines lacking MHC class I, MHC class 
II, or CD1 molecules were used either as targets for lysis by 
Vy2V62’ T cells in the presence of prenyl pyrophosphate 
antigens or as accessory cells to augment the proliferation 
of Vy2V62+ T cells in response to such antigens. The CD4’ 
yS T cell clone, HF.2, was used as the responder cell for 
the proliferation assays, because this clone required ac- 
cessory cells to respond to prenyl pyrophosphate antigens 
(see Figure 2A). Because similar accessory cell-depen- 
dent antigen-specific CD4+ up T cell clones proliferate to 
preprocessed peptide antigens only in the presence of 
accessory cells expressing the restricting MHC molecule 
(Sinigaglia et al., 1988), studies were performed to deter- 
mine whether expression of classical antigen-presenting 
molecules on the accessory cells was required for the rec- 
ognition of prenyl pyrophosphate antigens by this clone. 
The addition of MAbs specific for MHC class I, MHC 
class II, f%rn, or CDla, CD1 b, or CDlc molecules did not 
significantly block the recognition of mycobacterial anti- 
gens or MEP by CD4-CD8- Vy2V62+ T cell clones in both 
cytolytic and proliferative assays (data not shown). This 
suggested that known presentation elements may not 
present the nonpeptide prenyl pyrophosphate antigens. 
To assess further the requirement for MHC class II ex- 
pression, we examined MHC class II expression on the yS 
TCR transfectant DBS43. The DBS43 transfectant totally 
lacked expression of class II molecules (Figure !?.A), yet 
was able to recognize prenyl pyrophosphate antigens in 
theabsenceofothercells(seeFigure3). Toconfirmfurther 
that MHC class II does not present the nonpeptide anti- 
gens, the mutant MHC class II-negative cell line RJ-2.2.5, 
and its MHC class II-positive parent cell line Raji, were 
used as targets for lysis by the Vy2V62’ T cell clone 
DG.SF8 in the presence of prenyl pyrophosphate anti- 
gens. Staphylococcal enterotoxin A (SEA) was used as a 
control stimulus because it is recognized by VyPbearing 
y6 T cells when presented by MHC class II molecules (Rust 
et al., 1990). As expected, in the presence of SEA the 
DG.SF8 T cell clone lysed the class II-positive parent cell 
line, Raji, but failed to lyse the class II-negative mutant 
cell line, RJ-2.2.5 (Figure 58). In contrast, in the presence 
of a mycobacterial extract the DG.SF8 clone lysed both 
the Raji and the mutant RJ-2.25 line (Figure 58) indicat- 
ing that MHC class II expression is not required for the 
recognition of mycobacterial antigen-sensitized target 
cells. Similarly, a variety of class II-deficient EBV- 
transformed B cell lines functioned as target cells for a 
second Vy2VS2+ T cell clone LGC8, in the presence but 
not in the absence of a mycobacterial extract (Figure 5C). 
To assess further the requirement for classical class I 
molecules, we used the mutant APC 721.221, which lacks 
HLA-A, HLA-B, and HLA-C expression, and the mutant 
APC FO-1, which lacks f3*m expression (D’Urso et al., 
1991; Rajagopalan and Brenner, 1994) as accessory cells. 
Both mutant APCs presented the mycobacterial antigens 
to the APC-dependent y5 clone HF.2 (Figure 5D, experi- 
ment 1). Expression of CDla, CDlb, and CDlc molecules 
also was not required, since EBV-transformed B cell lines 
used in these experiments do not express these molecules 
(data not shown) yet presented prenyl pyrophosphate anti- 
gens. Taken together, these data utilizing MAb blocking, 
TCR transfectants, and mutant-presenting cell lines sug- 
gested that the recognition of prenyl pyrophosphate anti- 
gens by y6 T cells did not require classical MHC class I, 
MHC class II, or CD1 expression. 
Although MHC class I and II molecules were not required 
for the presentation of prenyl pyrophosphate antigens, it 
remained possible that the TAP1 and TAP2 or DMA and 
DMB molecules might play a role. To determine the re- 
quirement for these molecules, the mutant cell line 
721.174 was used as an APC. This cell line has deletions 
in the MHC locus resulting in a loss of class II molecules, 
the TAP1 and TAP2 peptide transporters that are critical 
for the peptide loading of class I molecules (Spies et al., 
1990) and the DMA and DMB molecules that play roles 
in the peptide loading of class II molecules (Denzin et al., 
1994). Despite these defects, the 721.174 cell line effi- 
ciently presented prenyl pyrophosphate antigens in a my- 
cobacterial extract to the HF.2 y5 T cell clone (Figure 5D, 
experiment 2). Thus, the requirementsforthe presentation 
of monoalkyl phosphate antigens to Vr2V62’T cell clones 
such as HF.2 were clearly distinct from the requirements 
for the presentation of protein antigens using MHC class 
I or class II antigen-presenting pathways. 
Prenyl Pyrophosphate Antigens Do Not Require 
Antigen Uptake or Processing 
Although the MHC class I and class II peptide loading 
pathways were not required for prenyl pyrophosphate anti- 
gen presentation, there may be other intracellular path- 
way(s) required for prenyl pyrophosphate antigen presen- 
tation. To assess this possibility, EBV-transformed B cells 
were fixed to prevent the uptake and processing of the 
prenyl pyrophosphate antigens. Then, the fixed cells were 
used as APCs for the APC-dependent yS clone HF.2. Both 
the untreated B cells and the fixed B cells were capable 
of presenting the antigens in a mycobacterial extract to 
the HF.2 clone (Figure 6, top, experiment 1; mean prolifer- 
ation of 17,290 cpm for the untreated cells versus 10,647 
cpm for the fixed cells). Similarly, both untreated and fixed 
B cells were capable of efficiently presenting synthetic 
isopentenyl pyrophosphate and the prenyl pyrophosphate 
antigens in a mycobacterial supernatant (Figure 6, bottom, 
experiment 2). In contrast, fixed PBMC failed to present 
antigen to the M. tuberculosis-specific CD4+ up T cell 
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Figure 5. Vy2VS2+ T Cells Respond to Prenyl 
Pyrophosphate Antigens in the Absence of 
MI-C Class II Molecules (HLA-DR, HLA-DO, 
HLA-DP, HLA-DMA, or HLA-DMB), Classical 
MHC Class I Molecules (HLA-A, HLA-B. or 
HLA-C), Plm-Dependent Molecules, andTAP 
TAP2 Transporters 
(A) The Vy2V62 TCR transfectant, DBS43, is 
MHC class II negative. MHC class II expression 
by the yS T cell clone, DGSF13, and the 
Vy2VS2 TCR transfectant, DBS43. was as- 
sessed by staining with class h-specific MAbs 
and analyzing by one-color flow cytometry. The 
MAbs used were anti-pan class II (IVA12), anti- 
HLA-DR (LB3.1) anti-HLA-DC1 (LeulO), and 
anti-HLA-DP (87121). Control MAb (P3) stain- 
ing is shown as open profiles, whereas class 
II staining is shown as closed profiles. 
(B) MHC class II expression is not required for 
the killing of target cells by yS T cells upon 
exposure to a mycobacterial extract. The Bur- 
kitt’s lymphoma, Raji, and its class h-deficient 
mutant, RJ-2.2.5, were used as chromium la- 
beled targets in a standard 4 hr cytotoxicity 
assay with the y6 clone, DG.SFE, in the ab- 
sence (open bars) or the presence of the super- 
antigen, SEA(striped bars)or aM. tuberculosis 
extract (closed bars). E:T was 1OO:l. Note that 
the recognition of the SEA superantigen by y6 
T cells required class II expression, whereas 
the recognition of mycobacterial extract did not. 
(C) Parent and mutant EBV lines lacking class 
II expression due to induced mutations (6.1.6 
and 721.174) or inherited mutations (Nacera 
and Ramia) were used as targets in a 4 hr cyto- 
toxicity assay as described above, except clone 
LGC6 was used as the effector in the absence 
(open bars) or the presence (closed bars) of M. 
tuberculosis extract. E:T was 31.6:1_ 
(D) Expression of classical MHC class I, pzrn- 
dependent molecules, MHC class II, TAP112, 
and DMAlDMB is not required for the recogni- 
tion of prenyl pyrophosphate antigens by the 
Vy2VS2+ HF.2 clone. The HF.2 T cell clone 
(APC dependent) was cultured with (experi- 
ment 1) the syngeneic EBV line DG.EBV, the 
parent EBV line 721, the mutant EBV line 
721.221 (lacking HLA-A, HLA-B and HLA-C), 
and the melanomacell line FO-1, (lacking 6?m), 
or with (experiment 2) 721, 721.221, and 
721.174 (lacking class II, TAPlITAP2. and 
DMAIDMB) in the absence (open bars) or pres- 
ence (closed bars) of M. tuberculosis extract. 
line DG.1 (data not shown). Therefore, the presentation 
of prenyl pyrophosphate antigens to y6 T cells did not 
require antigen uptake or processing. 
Prenyl Pyrophosphate Antigens Cannot 
be Pulsed on APCs 
We further determined whether the prenyl pyrophosphate 
antigens stably associated with APCs as do conventional 
protein or peptide antigens and superantigens for presen- 
tation to a6 T cells. Syngeneic EBV-transformed B cells 
were incubated for 4 hr with either a crude M. tuberculosis 
extract, MMP, MEP, or PPD and then washed. Whereas 
syngeneic EBV-transformed B cells pulsed with the myco- 
bacterial extract, or the PPD preparation stimulated the 
mycobacteria-specific DR7-restricted CD4+ ab T cell line 
DG.l (Porcelli et al., 1992), B cells pulsed with the prenyl 
pyrophosphate antigens did not stimulate the Vy2V62+ T 
cell clone DGSF68 (Figure 7). Since yS T cells themselves 
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Figure 6. Lack of Antigen Uptake and Processing Requirement for 
Prenyl Pyrophosphate Antigen Recognition 
The APC-dependent Vy2VS2’ T cell clone, HF.2, was cultured with 
unfixed or fixed EBV-transformed 6 cells (experiment 1, top) in the 
absence (open bars) or presence (closed bars) of M. tuberculosis ex- 
tract or (experiment 2, bottom) in the absence (open bars) or presence 
of mycobacterial supernatant (closed bars) or synthetic isopentenyl 
pyrophosphate (31.6 PM) (striped bars). APC were fixed by a 15 s 
exposure to 0.05% glutaraldehyde. 
may express a presenting element, the yS T cell clone 
DGSF66 was pulsed with the prenyl pyrophosphate anti- 
gens, treated with mitomycin C, and used as presenting 
cells for untreated DG.SF66 T cells. Again, no stimulation 
of the untreated DG.SF66 T cells was noted (data not 
shown). Further attempts to pulse prenyl pyrophosphate 
antigens onto syngeneic and allogeneic PBMC using 
phosphate-containing or phosphate-free wash buffers 
also were unsuccessful (data not shown). Thus, pulsing 
APC with synthetic and partially purified natural prenyl 
pyrophosphate antigens did not result in APC stimulatory 
for Vr2VS2’ T cells, suggesting that these antigens could 
not stably associate with the APC cell surface in an immu- 
nogenic form. Rather, thecontinual presence of these anti- 
gens was required for T cell activation. 
Discussion 
We have examined the presentation of nonpeptide prenyl 
pyrophosphate antigens to human $5 T cells. We find that 
the recognition of prenyl pyrophosphate antigens by 
Vy2VS2+ T cells can occur through an extracellular path- 
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Figure 7. Prenyl Pyrophosphate Antigens Cannot Be “Pulsed” onto 
APCs 
The syngeneic EN-transformed B cell line, DG.ESV. was treated with 
mitomycin C, pulsed with either crude mycobacterial extract, mono- 
methyl phosphate (MMP), monoethyl phosphate (MEP), or PPD by 
incubation for 4 hr at 37%. and then washed three times. The yS T 
cell clone, DG.SF68, or the mycobacteria-specific CD4+a6 T cell line, 
DG.1, then were cultured with the pulsed APC in the presence of 0.03 
nM rlL-2 for 48 hr. MEP and PPD were added as positive controls for 
each APC group (only the unpulsed control APC group is shown as 
the other groups gave similar levels of proliferation). 
way involving the secretion of prenyl pyrophosphate anti- 
gens by mycobacteria. Whereas cell-cell contact between 
y6 T cells (or between y6 T cells and other cell types) is 
required for prenyl pyrophosphate recognition, yS T cells 
do not require specialized accessory cells for recognition 
to occur. Moreover, antigen uptake and processing is not 
required for recognition by Vy2V62+ cells, as evidenced 
by the ability of mutant APCs lacking peptide loading path- 
ways and fixed APCs to present the prenyl pyrophosphate 
antigens. Finally, the expression of classical MHC class 
I, MHC class II, and CDla, CD1 b, or CDlc molecules is 
not required for prenyl pyrophosphate antigen recognition 
by y6 T cells, confirming some earlier studies (Fisch et 
al., 1990; Holoshitz et al., 1989, 1993). Clearly, Vy2V62+ 
T cells recognize prenyl pyrophosphate antigens in a man- 
ner distinct from that of a6 T cell recognition of conven- 
tional protein antigens, CD1 -restricted lipid antigens, and 
superantigens. 
In some aspects, nonpeptide prenyl pyrophosphate rec- 
ognition by yS T cells resembles peptide antigen recogni- 
tion by a6 T cells (Wyss-Coray et al., 1992; Yewdell and 
Bennink, 1992). Like the recognition of nonpeptide anti- 
gens, the recognition of peptide antigens by MHC class 
I- or MHC class II-restricted human T cells does not re- 
quire professional APCs due to the ability of T cells to 
present to other T cells through cell-cell contact (LaSalle 
et al., 1993). Moreover, like nonpeptide antigen recogni- 
tion, peptide antigen recognition does not require antigen 
uptake or processing, because peptides can directly bind 
to cell surface MHC class I or class II molecules (Hosken 
et al., 1969). There are, however, important differences 
between peptide recognition and prenyl pyrophosphate 
recognition. Whereas peptide antigens are presented by 
either MHC class I or class II molecules, prenyl pyrophos- 
phate antigens do not appear to use these molecules or 
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CD1 molecules in the recognition process. Moreover, 
whereas peptide antigens form stable complexes with 
MHC molecules on the surface of APCs, prenyl pyrophos- 
phate antigens do not. Finally, whereas exogenous pep- 
tide antigens must be generated from proteins by proteoly- 
sis (Moore et al., 1988; Sherman et al., 1992), the prenyl 
pyrophosphate antigens are secreted in an immunogenic 
form by several mycobacterial species. 
There is strong evidence that the recognition of prenyl 
pyrophosphate molecules is TCR mediated. First, this rec- 
ognition can be blocked by MAbs to the y8 TCR (Munk 
et al., 1990; Tanaka et al., 1994). Second, the yS T cell 
expansions noted in response to these molecules are re- 
stricted to $5 cells expressing the Vy2 (also termed Vy9) 
and V62 gene segments (De Libero et al., 1991; Kabelitz 
et al., 1991; Panchamoorthy et al., 1991; Tanaka et al., 
1994), and only y6 T cell clones expressing Vy2V62 TCR 
are reported to respond to the prenyl pyrophosphate anti- 
gens (Davodeau et al., 1993; De Libero et al., 1991). Fi- 
nally, transfection of cDNAs encoding a Vy2VS2 TCR into 
the TCR loss mutant of the afi T cell tumor, Jurkat, confers 
responsiveness to the nonpeptide prenyl pyrophosphate 
antigens, whereas transfer of cONAs encoding a VylVGl 
TCR do not (Bukowski et al., 1995). Thus, since recogni- 
tion involves the y6 TCR, the prenyl pyrophosphate mole- 
cules are likely to function as antigens for $5 T cells rather 
than as mitogens. 
Models of Prenyl Pyrophosphate 
Antigen Recognition 
Although our data are most consistent with TCR-mediated 
recognition of prenyl pyrophosphate molecules, it remains 
possible that these molecules function to enhance the rec- 
ognition of another ligand rather than acting as classical 
antigens. However, we favor models in which there is di- 
rect recognition of either the prenyl pyrophosphate mole- 
cules or the complex of the prenyl pyrophosphate mole- 
cules and a presenting element (Figure 8). In these 
models, the Vy2VS2 TCR binds to prenyl pyrophosphate 
antigens either in solution or at the cell surface with or 
without a presenting molecule(Figure8). If presenting mol- 
ecules exist for prenyl pyrophosphate antigens, they are 
not conventional MHC class I, MHC class II, or CD1 pro- 
teins. The hypothetical presenting molecules would be un- 
able to form stable complexes with prenyl pyrophosphate 
antigens and would bind these antigens rapidly (in min- 
utes), as evidenced by the rapid induction of calcium flux 
in spun T cells after antigen addition, but would also have 
high antigen dissociation rates. 
In the proposed models, we hypothesize that they6TCR 
binds directly to prenyl pyrophosphate antigens. Evidence 
for the direct recognition of foreign antigens by y8 T cells 
has been presented for the herpes simplex virus glycopro- 
tein gl (Sciammas et al., 1994) for allogeneic MHC class 
II and TL molecules (Schild et al., 1994) and for native 
tetanus toxin (H. B. et al., unpublished data). Moreover, 
the length of the 6 chain CDR3 region most resembles that 
of immunoglobulin heavy chains, leading some authors 
to suggest immunoglobulin-like recognition properties for 
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Figure 8. Possible Models of Prenyl Pyrophosphate Antigen Recog- 
nition 
Prenyl PP is prenyl pyrophosphate. Note that although TCR recogni- 
tion of the prenyl pyrophosphate antigens is diagrammed as involving 
cognate interactions with the antigen binding region of the TCR, recog 
nition through the framework regions of the TCR variable domain can- 
not be excluded. 
the yS TCR (Rock et al., 1994). Thus, the Vy2VS2 TCR 
could recognize prenyl pyrophosphate antigens in a fash- 
ion similar to that of antibodies that bind to soluble haptens 
such as dinitrophenol or azobezenearsonate, or to hapten- 
specific T cells (Morita et al., 1986; Rao et al., 1984a, 
1984b; Siliciano et al., 1986). However, the recognition of 
soluble prenyl pyrophosphate antigens, as with the recog- 
nition of soluble haptens by B or T cells, would not be 
expected to cross-link the TCR. This would make it neces- 
sary for the prenyl pyrophosphate antigens to associate 
with the cell surface if T cell activation is to occur. If recog- 
nition of soluble prenyl pyrophosphate antigens without 
a presenting molecule does occur, the cell-cell contact 
requirement for y8 T cell activation could be explained by 
the need for an additional interaction with a costimulatory 
or accessory molecule on a cell surface. 
Our data do not support models where prenyl pyrophos- 
phate antigens induce a change in the presenting cell, 
such as the induction of a heat shock protein or the chemi- 
cal modification of the cell surface that is recognized by 
the yS T cell. Such changes would have to be rapidly in- 
duced on fixed cells and rapidly lost, given our inability 
to effect stable changes in the APCs that can be detected 
by y6 T cells. Similarly, our data do not support models 
where prenyl pyrophosphate molecules stimulate cytokine 
secretion, which in turn specifically stimulates Vy2V62+ T 
cell proliferation and activation. Such a model would be 
inconsistent with the IL-2 release observed in response 
to prenyl pyrophosphate molecules by the Vy2V62 TCR 
transfectant but not the Vyl VSl TCR transfectant. Further- 
more, the mutant Jurkat T cell line used here was derived 
from an a6 T cell tumor unlikely to express unique yS T 
cell-specific cytokine receptors. 
Potential In Vivo Relevance of Extracellular 
Presentation of Prenyl Pyrophosphate Antigens 
Our data demonstrate that prenyl pyrophosphate antigens 
can use a novel extracellular pathway for antigen presen- 
tation distinct from the intracellular and extracellular path- 
ways used for antigens and superantigens presented by 
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MHC class I, MHC class II, and CD1 molecules. We hy- 
pothesize that the secretion of prenyl pyrophosphate anti- 
gens by mycobacteria and other bacteria allows y6 T cells 
in vivo to recognize these antigens directly without requir- 
ing antigen uptake and processing. In fact, the intracellular 
passage of prenyl pyrophosphate antigens through the 
acidic environment of endosomes and lysosomes would 
be expected to inactivate these compounds by the hydroly- 
sis of the pyrophosphate moiety from the prenyl chain 
(Logan, 1972). 
The rapid recognition of prenyl pyrophosphate antigens 
secreted by a number of microorganisms and presented 
by an extracellular pathway may allow Vy2V62’ T cells 
to complement the recognition of bacterial and parasitic 
protein antigens presented by intracellular pathways to 
ap T cells. Supporting this possibility, elevated levels of 
Vy2V62’ T cells are seen at least as early as 7 days after 
salmonella infection and 9 days after tularemia infection 
(Sumida et al., 1992). Moreover, systemic salmonella in- 
fections in humans (where bacteria can be cultured from 
the blood) are associated with the highest elevations of 
Vy2V62’ T cells (Hara et al., 1992). After activation by 
prenyl pyrophosphate antigens, these Vy2V62’T cells can 
secrete a number of cytokines, including IFNr (Barnes et 
al., 1992; Follows et al., 1992). Therefore, besides provid- 
ing critical cytokines required for the elimination of bacte- 
ria, yS T cells could also influence the differentiation of 
naive microbe-specific ap T cells into cells secreting TH1 
cytokines. Evidence for such a role for y6 T cells has re- 
cently been reported for listeria infections in the mouse 
(Ferrick et al., 1995). Clearly, the unique chemical struc- 
ture of the prenyl pyrophosphate antigens and the differ- 
ences in their requirements for recognition underscores 
the distinct nature of this antigen presentation system for 
yS T cells. The concepts of T cell recognition of conven- 
tional protein antigens and protein superantigens should 
be expanded to include the recognition of nonpeptide pre- 
nyl pyrophosphate antigens. 
Experimental Procedures 
Derivation of and Culture Conditions for T Cell Clones 
T cell lines and clones were maintained by periodic restimulation with 
phytohemagglutinin as previously described (Morita et al., 1994). The 
derivation of the CD4-CD8- and CD8+ y6 T cell clones and the weakly 
cylotoxic CD4’ y6 T cell clones, HF.2, JN.23, and JN.24, have been 
described (Morita et al., 1991; Spits et al., 1991; Tanaka et al., 1994). 
The DG.l line is a CD4’ PPD-specific us T cell line (Porcelli et al., 
1992)andthe2Hy.266.2cloneisaCD4+a~Tcellclone thatrecognizes 
myelin basic protein (residues 84-102) (Ota et al., 1990). SP-F3 is a 
CD4’ up T cell clone that recognizes tetanus toxoid C fragment (resi- 
dues 947-961) (Roncarolo et al., 1988; data not shown). 
Antigens 
Sonicated mycobacterial extract was prepared from a selected lot of 
M. tuberculosis strain H37Ra (Lot 77645990, Difco, Detroit, Michigan) 
or from cultured M. smegmatis as described (Morita et al., 1994). The 
prenyl pyrophosphate antigens from mycobacterial supernatant was 
partially purified from M. fortuitum as described (Tanaka et al., 1994). 
MEP was prepared and purified by anion exchange (Tanaka et al., 
1994). Monomethyl phosphate, isopentenyl pyrophosphate, and di- 
methylallyl pyrophosphate were obtained from Sigma. Staphylococcal 
enterotoxin B was obtained from Toxin Technology, Incorporated (Sar- 
asota, Florida). 
Mycobacterlal Culture and the Secretion 
of the Nonpeptlde Antlgen 
Separate cultures of M. foriuitum (a rapid growing mycobacterial spe- 
cies) were set up in parallel for the indicated period in Middlebrook’s 
media. At each timepoint, the optical density of the bacteria was mea- 
sured at 600 nm and the bacteria from 50 ml of media were harvested 
by centrifugation and then probe sonicated. The total bioadivity was 
determined for the spent media and the bacterial lysates by bioassay. 
We defined 1 U of bioactivity as the concentration of antigen necessary 
to achieve half-maximal proliferation of the DG.SF68 T cell clone. 
Assays for this experiment were performed at the same time and a 
standard preparation of mycobacteria with known biological activity 
was assayed to standardize the biological units. 
Mycobacterial secretion of antigen and its recognition by y6 T cells 
was simultaneously evaluated in a transwell system (Costar, Cam- 
bridge, Massachusetts). Live M. smegmatis in logarithmic phase 
growth (OD, was 0.7) were harvested from 5 ml of culture broth, 
washed three times in phosphate-buffered saline (PBS), and resus- 
pended in 0.5 ml PBS. Serial dilutionsof live mycobacteria, mycobacte- 
rial supernatant, synthetic isopentenyl pyrophosphate, MEP, and teta- 
nus toxin were added to the inner wells of a transwell in 0.1 ml. The 
inner well was separated from the outer well by a 0.4 pm membrane. 
Soluble antigens also were added directly to the outer wells of control 
cultures. Equal numbers (6 x lo6 cells/well) of the y6 T cell clone 
CP.1.15 and the mitomycin C-treated EBV-transformed B cell line 
DG.EBV were added to each outer well in 0.9 ml of RPM1 1640 media, 
and cultured for 24 hr. Then, the cells in the outer well were resus- 
pended, 200 ul of the cell suspension were added lo three wells of a 
96-well plate, pulsed with 13H]thymidine, and harvested 24 hr later. 
Soluble antigen preparation induced equal levels of specific prolifera- 
tion whether added lo the inner wells or added directly to the outer 
wells. 
Proliferation Assays 
T cell proliferation assays were performed as described (Morita et al., 
1994). In brief, T cells were plated in triplicate in round-bottomed 96- 
well plates at 5-10 x 10” T cells per well with 1 x lo5 irradiated 
syngeneic or allogeneic PBMC. Alternatively, PBMCs were replaced 
with mitomycin C-treated EBV-transformed lymphoblastoid B cells. 
Fixation of APC was by a 15 s exposure to 0.05% glutaraldehyde 
(Sigma, Missouri) followed by washing three times. Because the y6 
T cell response to mycobacteria is not MHC restricted (Kabelitz et al., 
199Ob), allogeneic cells were suitable APCs. The cultures were pulsed 
with 1 uCi of 13H]thymidine (2 Cilmmol) on day 1 and harvested 16- 
18 hr later. In some cases, low levels of rlL-2 (0.03 nM) were added 
lo the culture media. Mean proliferation and SEM are shown. 
For T cells lacking APC, resting y6 T cell clones were used 2-16 
weeks following restimulation. By this time, irradiated APCs had died 
and the cells were 98%-99+% T cells as determined by ungated one- 
color flow cytometry with the anti-TCRSl MAb (data not shown). For 
further purification, resting T cells were stained with MAbs against a 
macrophage surface marker (CD14, MAb 3ClO) and a B cell surface 
marker (complement receptor 2 or CD21, MAb HB5) and then nega- 
tively selected with magnetic beads (Morita 81 al., 1991). A portion of 
the resulting purified T cell population was stained with FITC-labeled 
control or anti-TCRGl MAbs and analyzed by flow cytometry. 
Stimulation of y6 T Cell Clone and yS TCR Transfectant 
with Antigen for IL-2 Release 
The y6 T cell clone DGSF13 and the y6 TCR transfectant DBS43 
have been described (Bukowski et al., 1995). In brief, the ~6 TCR 
transfectant DBS43 was derived by transfection of the y and 6 TCR 
cDNAs of the DGSF13 clone into the TCR-Jurkat mutant J.RT3-T3.5 
(Saito et al., 1987). For IL-2 release, T cells or TCR transfectants (1 
x IO5 cells) were cultured either alone or with varying numbers of 
mitomycin C-treated DG.EBV tumor cells(assyngeneic APCs), in wells 
of a 96-well flat-bottomed plate (ICN Biochemicals, Costa Mesa, Cali- 
fornia) in 200 hl of media. The prenyl pyrophosphate analog, MEP. 
was added as partially purified MEP (l/20 starting dilution). Phorbol 
myristate acetate, a required costimulator (Saito et al.. 1987), was 
present at 10 nglml. After 24 hr at 37’C, the supernatants were har- 
vested and diluted to 118. IL-2 release was determined by the prolifera- 
Presentation of Prenyl Pyrophosphate Antigens to y8 T Cells 
505 
tion of the IL-2-dependent T cell line CTLL-20 as described (Morita et 
al., 1991). IL-2 release was not noted in control wells lacking MEP. 
Measurement of Ca Flux by Flow Cytometry 
T cell clones were incubated in 5 PM indo-l (Molecular Probes, Incor- 
porated, Eugene, Oregon) at 1 x IO’ cells/ml for 30 min at 37’C. 
Indo-l-loaded T cells were diluted to 1 x 10e cells/ml and kept at 4% 
until use. T cells (without APC) then were incubated at 37OC for 2 min, 
analyzed for 30 s to establish baseline levels, and antigen was added. 
For “not spun” samples, the cells were analyzed for an additional 7 
min. For “spun” samples, the cells were analyzed for an additional 1 
min to establish baseline calcium flux after antigen addition. The T 
cells then were removed, centrifuged for 20 s in a microcentrifuge to 
effect cell-cell contact, and incubated for a further l-2 min at 37% 
The cells were resuspended, applied to the cytometer, and analyzed 
for an additional 5-6 min. As a positive control, TCR was cross-linked 
by the IgM anti-CD3 MAb, 2Ad-2A2 (a gift from Dr. Reinherz, Dana 
Farber Cancer Institute, Boston, Massachusetts). Maximum and mini- 
mum [Ca*+], levels were determined by the addition of ionomycin (2 
vglml from Sigma) and EGTA (80 mM), respectively. The mean ratio 
of indo-l fluorescence at 410/480 nm is shown. 
Measurement of Ca Flux In Individual Cells by Interactive 
Laser Cytometry 
T cell clones were loaded with indo-l (2 PM) in the absence of APCs 
as above, washed twice, and analyzed using an interactive laser 
cytometer (Meridian Instruments ACAS 570, Okemos, Michigan). For 
“not spun” samples, indo-l -loaded T cells (1 x lo8 cells/ml) were incu- 
bated at 37°C for 4 min, antigen was added, and the T cells plated 
on a glass cover slip. For “spun” samples, indo-l-loaded T cells (1 x 
lo6 cells/ml) were incubated at 37% for 4 min, antigen was added, 
and the T cells were centrifuged in a microcentrifuge to effect cell- 
cell contact. After 1 min at 37%, the cells were gently resuspended 
and plated on a glass cover slip. Plated T cells were visualized on an 
Olympus IMT-2 inverted fluorescence microscope and illuminated with 
355 nm UV light from an argon laser. The ratio of fluorescence emis- 
sion at 400 nm (bound Ca2+) to that at 480 nm (unbound Ca*+) was 
taken as a relative measure of [Ca-1. The ratios of indo-l fluorescence 
were represented by pseudocolor hues. A computer-interfaced xy 
scanning stage was used to generate quantitative two-dimensional 
images of [Ca*+], for individual T cells. lonomycin (2 pg/ml) was added 
as a positive control for maximal [Ca2+], levels. Representative micro- 
scope fields at 3-5 min after additions are shown. 
MAb Blocking Studies 
MAbs to MHC class I, MHC class II, pPm, and CD1 were; W6/32 (anti- 
pan class I), 887.7 (anti-class I), PA2.6 (anti-class I), IVA12 (anti-HLA- 
D), LB3.1 (anti-HLA-DR), L243 (anti-HLA-DR), 87121 .l (anti-HtA-DP), 
IVD12 (anti-HLA-DO), BBM.l (anti-&m), L368 (anti&m), OKr6 (anti- 
CDla), 4A7.6.2 (anti-CDlb), BCDlb2.1 (anti-CDlb). lOC3(anti-CDlc), 
and 3Cll (anti-CDld). Prior to T cell addition, MAbs were added as 
either dialyzed ascites fluid (11200 dilution), overgrown culture super- 
natant (114 dilution), or purified antibody (12.5 @g/ml) to cytotoxicity 
or proliferation assays with suboptimal concentration of prenyl pyro- 
phosphate antigens. All MAbs were shown to either block control T 
cell responses or to stain on FACS analysis. 
lmmunofluorescence Analysis 
For determination of MHC class II expression, the y6 T cells clone, 
DG.SF13, theVy2V62 TCR transfectant, DBS43, the EBV-transformed 
B cell line, 721, and the class II-negative deletion mutant of the 721 
cell line, 721.174, were stained with anti-class II MAbs. The MAbs 
used were anti-pan class II (IVA12), anti-HLA-DR (LB3.1), anti-HtA-DQ 
(LeulO), anti-HLA-DP (B7/21), or the control MAb (P3). The anti- 
HLA-DQ MAbs, SPV-L3 and IVD12, also were used and did not stain 
DBS43 (data not shown). Stained cells were analyzed by one-color 
flow cytometry performed with a FACsort flow cytometer using Lysis 
II software (Becton Dickenson and Company, Palo Alto, California) 
(Morita et al., 1994). 
Cytotoxiclty and PriMemtion Assays wfth MHC Ctass I, MHC 
Class II, and TAPlITAPP-Deficient Tumor APC 
Cytotoxicity was measured using a standard 4 hr s’Cr-release assay 
(Moritaetal.. 1991). Chromium-labeledtargetsandthey6Tcellclones, 
DG.SF8 or LGC6, were mixed at an E:T ratio of 1OO:l in the absence 
or continual presence of mycobacterial extract (1135 dilution) or the 
staphylococcal superantigen SEA (1 vg/ml). Targets cells were the 
Burkitt’s lymphoma Raji and its MHC class II-negative mutant, RJ- 
2.2.5 (Accolla, 1983); T5-1, and its class II-deficient mutant, 6.1.6 
(Gladstone and Pious, 1978); 721 and its class II deletion mutant, 
721.174 (DeMars et al., 1984); and the natural class II-deficient cell 
lines, Nacera and Ramia, derived from two patients with bare lympho- 
cyte syndrome (De P&al et al., 1985). The RJ-2.2.5, 6.1.6, Nacera, 
and Ramia mutants lack all class II molecules due to the absence of 
different transactivating factors for class II transcription (B&nichou and 
Strominger, 1991). The 721.174 mutant lacks class II genes, TAP1 
and TAP2 peptide transporter genes, and the DMA and DMB class II 
genes due to deletions in the MHC locus (DeMars et al., 1984; Denzin 
et al., 1994; Spies et al., 1990). The 721.221 mutant lacks cell surface 
expression of HLA-A, HLA-B, and HLAC (Shimizu and DeMars, 1989). 
The mutant melanoma cell line. FO-1, is &m deficient due to a defect 
in Brim gene expression (D’Urso et al., 1991) and lacks detectable 
assembled class I molecules as determined by reactivity with the W61 
32 MAb (Rajagopalan and Brenner, 1994). 
Pulsing of APCs 
APCs (as DG.EBV, a syngeneic EBV-transformed B cell line) were 
mitomycin C treated, and incubated with either a M. tuberculosis ex- 
tract (112 dilution), monomethyl phosphate (2.5 mM), monoethyl phos- 
phate (l/l00 dilution), or PPD (50 fig/ml) for 4 hr at 37%. The cells 
then were washed three times at 4% with Puck’s saline (phosphate- 
free buffer)or with PBS. The@Tcellclone, DGSF68, or the mycobac- 
teria-specific CD4’ aB T cell line, DG .I, were incubated with the pulsed 
APC in the presence of 0.03 nM rlL-2. PHFhymidine (1 $i) was added 
to the cultures on day 1 and the cells were harvested at day 2. Each 
pulsed APC group also was cultured with T cells in the continued 
presenceof M. tuberculosisextract, MMP. MEP, and PPDas a positive 
control for each APC group (only the unpulsed control APC group is 
shown). No proliferation was noted in the absence of T cells. In other 
experiments, different types of APC were used, including irradiated 
syngeneic and allogeneic PBMC, mitomycin C-treated allogeneic EBV 
cells, and mitomycin C-treated y6 T cells (DGSF68), and the length 
of pulsing was varied. 
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